Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed AlTurki

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|March 27, 2018
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization TherapyAhmed AlTurki, Riccardo Proietti, Hasan Alturki, et al.
Therapeutic Advances in Drug Safety|March 4, 2017
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidenceVincenzo Russo, Anna Rago, Riccardo Proietti, et al.
CJC Open|May 29, 2020
Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet TherapyChristopher Reid, Ahmed Alturki, Andrew Yan, et al.
CJC Open|April 1, 2024
Ultra-Low-Temperature Cryoablation for Ventricular Tachycardia: An Early Single-Centre Report of Acute ResultsPaula Sanchez-Somonte, Atul Verma, Luiz-Gustavo Bravosi Da Rosa, et al.
International Journal of Cardiology. Heart & Vasculature|February 21, 2024
Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncopeJacqueline Joza, Luiz Gustavo Bravosi da Rosa, Ahmed Alturki, et al.
Arrhythmia & Electrophysiology Review|August 30, 2019
Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised TrialsRoland R Tilz, Charlotte Eitel, Evgeny Lyan, et al.
The American Journal of Cardiology|November 5, 2019
Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular OutcomesAhmed AlTurki, Mariam Marafi, Ahmed Dawas, et al.
Arrhythmia & Electrophysiology Review|July 21, 2020
Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised TrialsRoland R Tilz, Charlotte Eitel, Evgeny Lyan, et al.
Journal of Arrhythmia|June 28, 2024
Meta-analysis evaluating apixaban in patients with atrial fibrillation and end-stage renal disease requiring dialysisAhmed AlTurki, Mariam Marafi, Ahmed Dawas, et al.
Circulation. Arrhythmia and Electrophysiology|January 17, 2020
Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery: A Systematic Review and Meta-AnalysisAhmed AlTurki, Mariam Marafi, Riccardo Proietti, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|March 27, 2018
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization TherapyAhmed AlTurki, Riccardo Proietti, Hasan Alturki, et al.
Therapeutic Advances in Drug Safety|March 4, 2017
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidenceVincenzo Russo, Anna Rago, Riccardo Proietti, et al.
CJC Open|May 29, 2020
Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet TherapyChristopher Reid, Ahmed Alturki, Andrew Yan, et al.
CJC Open|April 1, 2024
Ultra-Low-Temperature Cryoablation for Ventricular Tachycardia: An Early Single-Centre Report of Acute ResultsPaula Sanchez-Somonte, Atul Verma, Luiz-Gustavo Bravosi Da Rosa, et al.
International Journal of Cardiology. Heart & Vasculature|February 21, 2024
Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncopeJacqueline Joza, Luiz Gustavo Bravosi da Rosa, Ahmed Alturki, et al.
Arrhythmia & Electrophysiology Review|August 30, 2019
Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised TrialsRoland R Tilz, Charlotte Eitel, Evgeny Lyan, et al.
The American Journal of Cardiology|November 5, 2019
Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular OutcomesAhmed AlTurki, Mariam Marafi, Ahmed Dawas, et al.
Arrhythmia & Electrophysiology Review|July 21, 2020
Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised TrialsRoland R Tilz, Charlotte Eitel, Evgeny Lyan, et al.
Journal of Arrhythmia|June 28, 2024
Meta-analysis evaluating apixaban in patients with atrial fibrillation and end-stage renal disease requiring dialysisAhmed AlTurki, Mariam Marafi, Ahmed Dawas, et al.
Circulation. Arrhythmia and Electrophysiology|January 17, 2020
Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery: A Systematic Review and Meta-AnalysisAhmed AlTurki, Mariam Marafi, Riccardo Proietti, et al.
Pageof 5